These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 315413)

  • 21. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
    Casonato A; Sartori MT; Pontara E; Bertomoro A; Dannhäuser D; Girolami
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):567-73. PubMed ID: 1768767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
    Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor VIII/von Willebrand factor protein: sensitivity of periodic acid Schiff stain to carbohydrate deficiency.
    Gralnick HR; Jackson GM; Williams SB; Cregger MC
    Blood; 1982 Jun; 59(6):1310-6. PubMed ID: 6805533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between bleeding time and platelet adherence to artery subendothelium.
    Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
    Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 26. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The factor VIII abnormality in severe von Willebrand's disease.
    Zimmerman TS; Abildgaard CF; Meyer D
    N Engl J Med; 1979 Dec; 301(24):1307-10. PubMed ID: 315519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Desmopressin in hemophilia A and Von Willebrand's disease].
    Castro Cabezas M; de Graaf JC; Kraayenhagen RJ; Freen M; Poortman J; Hart HC
    Ned Tijdschr Geneeskd; 1991 Mar; 135(9):367-71. PubMed ID: 1901629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.
    Casonato A; Pontara E; Bertomoro A; Cattini MG; Soldera C; Girolami A
    Haematologica; 2003 Jun; 88(6):688-93. PubMed ID: 12801845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
    Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sensitive ELISA for von Willebrand factor (vWf:Ag).
    Ingerslev J
    Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia.
    Rahmani R; Rozen P; Papo J; Iellin A; Seligsohn U
    Isr J Med Sci; 1990 Sep; 26(9):504-9. PubMed ID: 2121664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR; Zimmerman TS
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The factor VIII/von Willebrand factor complex: basic and clinical issues.
    Federici AB
    Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein.
    Fukui H; Yoshioka A; Mikami S; Takase T; Fujimura Y; Takahashi Y; Nishino M; Iwagaki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):839-50. PubMed ID: 121660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.